Frank T Maziarski, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2328 N 186th St, Shoreline, WA 98133 Phone: 205-364-7980 Fax: 206-367-2916 |
Roger A. Strand, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 734 N 190th St, Shoreline, WA 98133 Phone: 206-542-4878 Fax: 206-542-4878 |
News Archive
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
Although there appears to be general agreement about tax code and entitlement changes that would begin next year and tally more than $1 trillion over 10 years, the initial installment of deficit reduction has become a sticking point between the White House and GOP leaders. Meanwhile, the Washington Post checks the facts on entitlement "spending cuts."
CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America.
For the first time in this disease area, researchers at the SGI have identified 80 genes involved in the inflammatory and neuro-degenerative pathways of MS, based on a 40% genome scan comparing the genetic profile of a total of 1,800 people with MS and healthy individuals in different populations.
› Verified 5 days ago